IRIS
Pizzato, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.197
EU - Europa 615
AS - Asia 466
SA - Sud America 110
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 4.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.193
SG - Singapore 280
IT - Italia 234
CN - Cina 97
BR - Brasile 96
UA - Ucraina 94
FI - Finlandia 64
SE - Svezia 47
DE - Germania 45
GB - Regno Unito 42
ID - Indonesia 20
VN - Vietnam 20
RU - Federazione Russa 19
NL - Olanda 17
TR - Turchia 13
AT - Austria 12
FR - Francia 7
BG - Bulgaria 5
CL - Cile 5
CZ - Repubblica Ceca 5
JO - Giordania 5
ZA - Sudafrica 5
IN - India 4
AR - Argentina 3
BD - Bangladesh 3
BY - Bielorussia 3
HK - Hong Kong 3
HU - Ungheria 3
PK - Pakistan 3
TW - Taiwan 3
UZ - Uzbekistan 3
VE - Venezuela 3
CA - Canada 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
LT - Lituania 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
SI - Slovenia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
PS - Palestinian Territory 1
RS - Serbia 1
UY - Uruguay 1
Totale 4.404
Salva come PNG Salva come JPEG
Città #
Fairfield 508
Chandler 281
Ashburn 266
Woodbridge 249
Seattle 224
Jacksonville 219
Wilmington 188
Cambridge 176
Singapore 162
Houston 159
Santa Clara 126
Columbus 103
Ann Arbor 96
Princeton 84
San Mateo 81
Trento 78
New York 38
Beijing 30
Helsinki 27
Como 26
San Diego 23
Dearborn 20
Jakarta 20
London 15
Moscow 15
Munich 15
Rome 14
Dong Ket 12
Council Bluffs 11
San Paolo di Civitate 9
Verona 9
Boardman 7
Falkenstein 7
Izmir 7
Los Angeles 7
Guangzhou 6
Milan 6
São Paulo 6
Turin 6
Vienna 6
Washington 6
Bremen 5
Dallas 5
Fort Worth 5
Fremont 5
Sofia 5
Brno 4
Brugherio 4
Düsseldorf 4
Hefei 4
Jinan 4
Johannesburg 4
Riva Del Garda 4
Volargne 4
Budapest 3
Hong Kong 3
Irvine 3
Islington 3
Kilburn 3
Lappeenranta 3
Minsk 3
Nuremberg 3
Prescot 3
Salvador 3
Springfield 3
Tashkent 3
Aberdeen 2
Altamura 2
Amsterdam 2
Aparecida de Goiânia 2
Belo Horizonte 2
Bourgoin-Jallieu 2
Brasília 2
Busto Arsizio 2
Cernusco sul Naviglio 2
Dublin 2
Frankfurt am Main 2
Karachi 2
Lagundo 2
Lyon 2
Nanjing 2
Napoli 2
North Bergen 2
Norwalk 2
Osasco 2
Padova 2
Pescara 2
Pisa 2
Silea 2
São Bernardo do Campo 2
Tolmin 2
Toronto 2
Vicenza 2
Villa Lagarina 2
Volta Redonda 2
Almaty 1
Alpestre 1
Ananindeua 1
Arnsberg 1
Atyrau 1
Totale 3.504
Salva come PNG Salva come JPEG
Nome #
SERINC5 as a new restriction factor for human immunodeficiency virus and murine leukemia virus 154
SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins 140
The antagonism of HIV Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor 135
A bipartite structural organization defines the SERINC family of HIV-1 restriction factors 128
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation 127
The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild 124
Retroviral factors promoting infectivity. 123
SARS-CoV-2 and the Host Cell: A Tale of Interactions 116
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration 116
Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. 108
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3 108
Galanin pathogenic mutations in temporal lobe epilepsy 108
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles 106
Effect of High-Energy Milling on the Dissolution of Anti-HIV Drug Efavirenz in Different Solvents 104
Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. 100
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists 99
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. 96
Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior 96
Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry. 95
Gene Therapy of Glioblastoma Multiforme with a Bicistronic Retroviral Vector Expressing Human IL-2 and HSV-tK. 92
TRIM5 is an innate immune sensor for the retrovirus capsid lattice. 92
Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. 91
A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. 89
Effect of differential growth conditions on the dTTP pool size in herpes simplex virus-infected Vero cells. 88
Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. 86
Progress with retroviral gene vectors. 86
Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. 83
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. 83
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. 81
Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. 81
Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection. 80
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 80
Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. 78
Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26 78
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. 77
Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5 77
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. 74
Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions. 73
Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. 72
Determination of HPRT mutant frequency and molecular analysis of T-lymphocyte mutants derived from coke-oven workers. 69
The activity of Nef on HIV-1 infectivity. 66
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 58
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. 54
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 51
Retrovirus vectors. 49
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. 49
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity 38
Viral particles imaging through evanescent wave scattering in a total internal reflection laser microscope 36
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity 36
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 33
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 29
The impact of infection risk communication format on tourism travel intentions during COVID-19 29
Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals 27
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 27
Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the Val Venosta/Vinschgau: the CHRIS COVID-19 study protocol 25
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity 23
A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation 18
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample 13
Totale 4.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 345
Totale 22.977
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020255 0 0 0 0 0 0 0 0 117 46 35 57
2020/2021726 9 69 30 96 102 44 48 56 46 74 99 53
2021/2022481 22 32 8 20 12 31 7 106 48 49 59 87
2022/2023607 63 68 6 69 52 87 9 54 113 35 31 20
2023/2024332 20 20 18 20 34 84 21 22 5 13 12 63
2024/2025922 17 11 75 247 79 166 115 82 130 0 0 0
Totale 4.554